Literature DB >> 565251

Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model.

T U Semple, L A Quinn, L K Woods, G E Moore.   

Abstract

Three tumor cell lines (COLO 201, COLO 205, and COLO 206) have been established from ascites fluid obtained from a male patient with adenocarcinoma of the colon. In addition to the tumor lines, two lymphoid lines (COLO 197 and COLO 200) have been established from the same patient, with one line from the original biopsy and one from peripheral blood. Characterization of the tumor cell lines revealed four cell types that differ from most colon cell lines reported by others. Chromosome markers were identical in COLO 201 and COLO 205. A long-arm isochromosome 5 observed in COLO 201 and COLO 205 was absent in COLO 206. Statistical analysis of autosomal polysomy revealed that these cell lines were stable and indicated that there may be a cytogenetic basis for the three predominant types of cell morphology. The lymphoid cell line derived from the peripheral blood had a normal male karyotype. The lymphoid cell line derived from a biopsy specimen had a mode of 46 and a deleted chromosome 7 marker. Both lymphoid cell lines had B-cell characteristics. These autochthonous cell lines have been used for immunological studies in cytotoxicity assays and immunoglobulin characterization.

Entities:  

Mesh:

Year:  1978        PMID: 565251

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation.

Authors:  Ryan B Corcoran; Dora Dias-Santagata; Kristin Bergethon; A John Iafrate; Jeffrey Settleman; Jeffrey A Engelman
Journal:  Sci Signal       Date:  2010-11-23       Impact factor: 8.192

2.  Establishment of a human cancer cell line with high potential for peritoneal dissemination.

Authors:  H Kotanagi; Y Saito; N Shiozawa; K Koyama
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

3.  Reproducibility: changing the policies and culture of cell line authentication.

Authors:  Leonard P Freedman; Mark C Gibson; Stephen P Ethier; Howard R Soule; Richard M Neve; Yvonne A Reid
Journal:  Nat Methods       Date:  2015-06       Impact factor: 28.547

4.  Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.

Authors:  B T Hill; L Y Dennis; X T Li; R D Whelan
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Fine structure and immunofluorescent studies of the WISH cell line.

Authors:  W D Meek; W L Davis
Journal:  In Vitro Cell Dev Biol       Date:  1986-12

6.  Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon.

Authors:  Thanemozhi G Natarajan; Bhaskar V Kallakury; Christine E Sheehan; Margaret B Bartlett; Natarajan Ganesan; Anju Preet; Jeffrey S Ross; Kevin T FitzGerald
Journal:  Cancer Cell Int       Date:  2010-04-30       Impact factor: 5.722

7.  Dynamic Switch Between Two Adhesion Phenotypes in Colorectal Cancer Cells.

Authors:  Yue Geng; Siddarth Chandrasekaran; Sivaprakash Agastin; Jiahe Li; Michael R King
Journal:  Cell Mol Bioeng       Date:  2013-11-14       Impact factor: 2.321

8.  Characterization of a human colonic adenocarcinoma cell line, LS123.

Authors:  L P Rutzky; B C Giovanella; B H Tom; C I Kaye; P D Noguchi; B D Kahan
Journal:  In Vitro       Date:  1983-02

9.  Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.

Authors:  S Apasov; M Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  p53 mutations in flat- and polypoid-type colorectal tumors detected by temperature-gradient gel electrophoresis.

Authors:  Y Yamamura-Idei; K Satonaka; T Fujimori; S Maeda; T Chiba
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.